Pathway Genomics to Present at the 2017 UBS Global Healthcare Conference - Pathway Genomics
Pathway Genomics is proud to celebrate 10 successful years as a CLIA and CAP accredited clinical laboratory!

Pathway Genomics to Present at the 2017 UBS Global Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)–Pathway Genomics, an innovative commercial-stage genomics company, announced today that Dr. Michael Nova, Chief Innovation Officer, and Kamal Adawi, Chief Financial Officer, will present at the 2017 UBS Global Healthcare Conference. This event will be held at the Grand Hyatt in New York City on Monday, May 22nd through May 24th. Pathway’s presentation will take place Monday, May 22, 2017 at 3:00 p.m. EDT. The presentation will be available on

“Pathway has a great relationship with UBS and we are honored to be a part of such an important conference,” said Jim Plante, Founder & CEO. “We are excited to share our upcoming advancements in genetic testing, artificial intelligence, personalized medicine and wellness.”

About Pathway Genomics

Founded in 2008, Pathway Genomics offers digital healthcare and genetic testing. Based in San Diego, CA our CLIA and CAP accredited clinical laboratory provides physicians and their patients in 50+ countries with actionable and accurate precision healthcare information to improve health and wellness. The company’s program with IBM Watson is a smartphone app that merges artificial intelligence and deep learning with personal genetic information. The app provides users and physicians with precision health and wellness information based on the individual’s health history.

Pathway believes in the power of “genetics first” to help make proactive, informed decisions about health and lifestyle. Our physician-ordered tests include assays for diet and weight loss, circulating tumor DNA (liquid biopsy), hereditary cancer, drug response and carrier screening. For more about Pathway Genomics, visit and follow us on Facebook, LinkedIn and Twitter.


Pathway Genomics
Investor Relations
Kamal Adawi, 858-900-3002